Skip to main content

Table 2 Patients by subtypes

From: Axillary ultrasound for predicting response to neoadjuvant treatment in breast cancer patients—a single institution experience

 

N = 244

%

Positive AUS

65

26.6

Luminal

35

28.2

Her-2 + 

19

24.4

TN

11

26.2

pCR

89

36.5

Luminal

15

12.1

Her-2 + 

55

70.5

TN

19

45.2

pCR in positive AUS

20

30.8

Luminal

1

2.9

Her-2 + 

13

68.4

TN

6

54.5

  1. AUS axillary ultrasound, Her-2 human epidermal growth factor receptor 2, pCR pathologic complete response, TN triple negative
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us